KAYLA SIVILS: Open Payments
NPI 1366122111 · JOPLIN, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,074 in 85 payments from 14 companies in 2025. Trend: 2023 $16 · 2024 $0 · 2025 $2,074
Food & beverage: $2,070Education: $4
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 12 | $312 |
| E.R. Squibb & Sons, L.L.C. | 8 | $277 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $248 |
| Axsome Therapeutics, Inc. | 6 | $188 |
| Alkermes, Inc. | 9 | $170 |
| Collegium Pharmaceutical, Inc. | 5 | $166 |
| Janssen Pharmaceuticals, Inc | 8 | $165 |
| ABBVIE INC. | 10 | $147 |
| Vanda Pharmaceuticals Inc. | 3 | $93 |
| Teva Pharmaceuticals USA, Inc. | 5 | $84 |
Products named: COBENFY, REXULTI, CAPLYTA, Auvelity, ARISTADA, Jornay PM, VRAYLAR, ABILIFY ASIMTUFII.
Industry payments across MO — which companies pay providers there.
